The Vascular Services Department at St. Francis Hospital is dedicated to providing a broad range of treatment options in the area of vascular surgery and catheter-based interventions for vascular disease. St. Francis Hospital has the distinction of being New York State’s only specialty designated heart center. As a result, it performs a proportionately higher number of cardiac procedures. Our cardiac expertise has enabled us to be one of the nation’s earliest pioneers in treating vascular disease.
Our department has the second largest caseload of abdominal aneurysm repairs in New York State. We offer patients two alternatives to repairing abdominal aortic vascular disease – traditional open surgery and, when appropriate, a less invasive technique that uses catheters inserted through two or three small incisions in the groin area. Not only is St. Francis Hospital one of the first hospitals in the country to perform endovascular repair of aortic aneurysms, it has a nearly perfect success rate in implanting stents.
We also perform the state’s largest caseload of carotid endarterectomy,
a surgical procedure to remove plaque in blocked carotid arteries in the neck that supply oxygen to the brain. In addition, as a clinical site for one of the
nation’s most prominent trials in carotid artery stenting, St Francis Hospital was the first Long Island Hospital to perform this less invasive technique using balloon catheters and stenting techniques to clear blockages in the arteries that lead to the brain.
St. Francis Hospital remains a clinical site for some of the nation’s most prominent trials in carotid artery stenting. These include SAPPHIRE and CREST, which compare stenting to the surgical approach to treatment.
Through data obtained from our ongoing participation in clinical studies, and the use of expanded facilities and enhanced technology, our mission is to remain at the forefront of treating vascular disease.
Back to Top
- Vascular disease
- Endovascular repair
- Carotid artery blockages
- Aortic abdominal aneurysms
Back to Top
Surgical Repair for Aortic abdominal Aneurysms
Aortic abdominal aneurysms affecting the abdominal aorta, represent a serious manifestation of atherosclerosis, or hardening of the arteries if undetected and left untreated, aneurysms can expand and rupture. When this occurs, emergency treatment is needed sometimes requiring open surgery.
Endovascular Stenting for Aortic Abdominal Aneurysms
This catheter-based technique provides a minimally invasive treatment of aortic aneurysms. The procedure time is usually under 90 minutes, posing minimal exposure to X-rays and resulting in less blood loss than during traditional surgical repair. It also often results in significantly shorter hospitalizations and quicker recoveries.
A surgical procedure requiring an open incision to remove the plaque from blocked carotid arteries. This traditional surgery poses relatively low risk of mortality of stroke when performed by experienced teams.
Carotid Artery Stenting
A wire mesh coil is inserted through a catheter to hold open blocked carotid arteries that lead to the brain, offering an alternative to a surgical approach known as carotid endarterectomy.
Peripheral Vascular Treatments
St. Francis Hospital’s vascular laboratory features digital imaging technology that generates high-definition images needed to perform diagnostic peripheral vascular studies and interventional therapies. Available treatments include angioplasty techniques to reopen arteries supplying blood to the kidneys, legs or arms.
Back to Top
Research and Clinical Trials
Current clinical research trials are being undertaken in low-risk or healthier
patients. At the present time Medicare will allow carotid stenting only in those patients who are high-risk and who are symptomatic with a history of prior
Transient Ischemic Attack (TIA) or Cerebrovascular Accident (CVA). This department will soon be participating in a new clinical trial to further evaluate the role of carotid stenting in low-risk patients called ACT I (Abbott).
It is our hope that with the data obtained through these trials, the
role of carotid stenting will continue to expand and that over the next
several years, 80-90% of carotid revascularization will be treated this way.
Back to Top